Newsletter | September 9, 2020

09.09.20 -- Why Is Antibiotic Development In The U.S. Disappearing?

Featured Editorial
Industry Insights
Key Questions For The Effective Implementation Of eCOAs In Your Clinical Trial

With the industrywide push toward patient-centricity, electronic clinical outcome assessments (eCOAs) have become a more widely used strategy to streamline patient data collection, provide real-time access to data for review and monitoring, enhance patient engagement, and improve the integrity and accuracy of clinical studies. Here are answers to some commonly asked questions about eCOAs.

Vendor Qualification vs. Requalification Audits: What’s The Difference?

When supporting vendor qualification and management programs there are different audits to consider. This article defines the differences and how to identify potential risks for your program.

The Next Big Step Toward A Collaborative Clinical Trial Ecosystem: Three Perspectives

Highlights from Veeva’s Innovation Theater presentation at DIA 2020: Veeva is joined by Vertex Pharmaceuticals, Inc. and the University of Louisville in an informative discussion about opportunities to streamline information sharing for faster trials and improving the site and patient experience.

How Technology And Relationships Can Improve Feasibility

Conducting a feasibility study is an essential and necessary step to starting up a clinical trial. The good news is that the whole approach has the ability to change for the better by initiating and adopting some enhancements.

Remote Trial Management: Remote Investigator Meetings And Site Initiation Visits

TransPerfect's Trial Interactive and MANA RBM have led the charge for digital and remote trial conduct over a combined 20+ years. MANA RBM CEO, Penny Manasco, M.D., recently contributed to our ongoing webinar series focused on adapting to challenges by enabling remote capabilities. Following are some highlights and main takeaways from Penny's responses to participants who wanted to learn more about how to get started with remote solutions. 

Development Of Qualified Cold Chain Solution For Vaccine Transport To Uganda

Maintaining the cold chain is a challenge when handling biologics such as vaccines, particularly when the clinic is in a remote location. Learn more about how Fisher Bioservices developed a qualified cold chain solution to transport Ebola vaccines to Uganda.

High-Quality, Audit-Ready Clinical Research Driven By Digital Data Management

A contract research organization (CRO) focused on quality needed to more thoroughly document clinical studies for sponsors, regulatory authorities, and other auditors. With a cloud-based, unified IBM Clinical Development platform, the CRO can now quickly create accurate digital records of every action taken, including granting users access and updating study protocols.

5 Ways To Adapt Your Neurodegenerative Disease Trial To The World Of COVID-19

When COVID-19 exploded around the world, in-progress neurodegenerative disease trials — as well as studies preparing to launch — were faced with a sudden and unexpected challenge: how to adapt their approach with the least disruption possible. This ebook provides practical tips for adjusting study operations to overcome unforeseen disruptions.


Wednesday, September 16, 2020 | 11:00 AM EDT

DIA NOW is your comprehensive, personalized resource for the latest trends and up-to-the-minute updates on a wide variety of critical issues in the life sciences arena. Access recorded sessions from the more than 60 global meetings taking place around the world annually, as well as breaking news and analysis from DIA’s publishing group.

Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.